InMed Pharmaceuticals (INM) Inventory (2021 - 2025)

InMed Pharmaceuticals' Inventory history runs 5 years deep, the most recent figure standing at $947898.0 for Q4 2025.

• On a quarterly basis, Inventory fell 14.09% year-over-year to $947898.0 in Q4 2025; TTM through Dec 2025 was $947898.0, a 14.09% decrease from a year earlier, with the FY2025 full-year figure at $961173.0, down 22.76% from the prior year.
• Inventory climbed to $947898.0 in Q4 2025 per INM's latest filing, from $890807.0 in the prior quarter.
• Across five years, Inventory topped out at $2.5 million in Q2 2022 and bottomed at $744839.0 in Q4 2023.
• The 5-year median for Inventory is $1.2 million (2024), against an average of $1.3 million.
• Across the five-year window, Inventory surged 63.17% in 2022 and sank 53.84% in 2023, its largest moves.
• Year by year, Inventory stood at $988822.0 in 2021, then jumped by 63.17% to $1.6 million in 2022, then sank by 53.84% to $744839.0 in 2023, then surged by 48.13% to $1.1 million in 2024, then slipped by 14.09% to $947898.0 in 2025.
• Per Business Quant, the three latest INM Inventory figures stand at $947898.0 (Q4 2025), $890807.0 (Q3 2025), and $961173.0 (Q2 2025).